Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Syneos Health Inc (SYNH)

Syneos Health Inc (SYNH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Syneos Health Announces Pricing of Secondary Offering of Common Stock

Syneos Health, Inc. (Nasdaq: SYNH) (the "Company" or "Syneos Health"), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization) and a CCO (Contract...

SYNH : 54.27 (-0.86%)
Syneos Health Announces Secondary Offering of Common Stock

Syneos Health, Inc. (Nasdaq: SYNH) (the "Company" or "Syneos Health"), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization) and a CCO (Contract...

SYNH : 54.27 (-0.86%)
Update: Syneos Health to Present at the Baird 2020 Global Healthcare Conference at 12:15 p.m. ET Today

Syneos Health (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization) and a CCO (Contract Commercial Organization), today announced...

SYNH : 54.27 (-0.86%)
Syneos Health (SYNH) Down 8.2% Since Last Earnings Report: Can It Rebound?

Syneos Health (SYNH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

SYNH : 54.27 (-0.86%)
Syneos Health to Present at the Baird 2020 Global Healthcare Conference

Syneos Health (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization) and a CCO (Contract Commercial Organization), today announced...

SYNH : 54.27 (-0.86%)
Syneos Health-Idorsia Collaborate to Launch Daridorexant in US

Syneos Health (SYNH) inks deal with Idorsia to commercialize the treatment for insomnia in the United States.

HOLX : 62.53 (-1.11%)
QGEN : 50.02 (+0.20%)
TMO : 426.69 (-1.44%)
SYNH : 54.27 (-0.86%)
Syneos Health (SYNH) Q2 Earnings Top Estimates, Margins Down

Syneos Health (SYNH) wins 35 COVID-19 related projects through the second quarter.

HOLX : 62.53 (-1.11%)
TMO : 426.69 (-1.44%)
WST : 276.38 (+0.52%)
SYNH : 54.27 (-0.86%)
Syneos Health (SYNH) Q2 Earnings and Revenues Surpass Estimates

Syneos Health (SYNH) delivered earnings and revenue surprises of 20.83% and 0.92%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

SYNH : 54.27 (-0.86%)
Syneos Health Reports Second Quarter 2020 Results

Highlights

SYNH : 54.27 (-0.86%)
3 Growth Stocks with STRONG Technicals

Growth stocks have driven the rally since March. I've found 3 growth stocks with solid fundamentals and strong technical indicators: Horizon Therapeutics (HZNP), Tesla (TSLA), and Syneos Health (SYNH)....

HZNP : 78.44 (+0.62%)
TSLA : 435.12 (+2.76%)
SYNH : 54.27 (-0.86%)
SPYG : 48.53 (-1.90%)
SPYV : 30.68 (-0.97%)
Senseonics Holdings (SENS) Catches Eye: Stock Jumps 5.7%

Senseonics Holdings (SENS) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.

SENS : 0.3816 (-4.60%)
SYNH : 54.27 (-0.86%)
Allscripts (MDRX) Looks Good: Stock Adds 9.1% in Session

Allscripts (MDRX) saw a big move last session, as its shares jumped more than 9% on the day, amid huge volumes.

MDRX : 8.13 (-1.57%)
SYNH : 54.27 (-0.86%)
10x Genomics (TXG) Looks Good: Stock Adds 6.2% in Session

10x Genomics (TXG) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

SYNH : 54.27 (-0.86%)
TXG : 119.93 (-0.17%)
Syneos Health (SYNH) Up 9.3% Since Last Earnings Report: Can It Continue?

Syneos Health (SYNH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

SYNH : 54.27 (-0.86%)
Daiichi Sankyo and Syneos Health(R) Form Strategic Coalition for Development of Daiichi Sankyo's ADC Oncology Pipeline

Daiichi Sankyo, Inc. (hereafter, Daiichi Sankyo) announced that it has entered into a strategic agreement with Syneos Health(R) (Nasdaq:SYNH). The companies are coming together to form a coalition to accomplish...

SYNH : 54.27 (-0.86%)
Syneos Health to Present at Upcoming Investor Conferences

Syneos Health (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization) and a CCO (Contract Commercial Organization), today announced...

SYNH : 54.27 (-0.86%)
Syneos Health to Present at the UBS Virtual Global Healthcare Conference

Syneos Health (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization) and a CCO (Contract Commercial Organization), today announced...

SYNH : 54.27 (-0.86%)
Syneos Health (SYNH) Tops Q1 Earnings Estimates, Margins Down

The coronavirus impact results in inaccessibility of several of Syneos Health's (SYNH) clinical trial sites.

BIIB : 271.08 (-1.56%)
LLY : 152.67 (+0.13%)
SYNH : 54.27 (-0.86%)
APHA : 4.59 (-1.50%)
Syneos Health (SYNH) Beats Q1 Earnings and Revenue Estimates

Syneos Health (SYNH) delivered earnings and revenue surprises of 9.68% and 2.05%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

SYNH : 54.27 (-0.86%)
Syneos Health Reports First Quarter 2020 Results

Highlights

SYNH : 54.27 (-0.86%)

Van Meerten Stock Picks

5 Great Small Caps
Summary 100% technical buy signals.
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar